Delivery Order SPE2DB22D1017-SPE2DB24FF4YP
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.60 firm fixed-price delivery order is for the supply of Lidocaine 5% patches, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is for the delivery of lidocaine 5% patches. The $1,752.79 firm fixed price delivery order has an ultimate completion date of April 5, 2024. This award is not associated with any set-aside programs. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- This federal contract award, valued at $13,611.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of 4564185827 - Lidocaine 5% Patch 30s, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a period of performance through April 8, 2024. No set-aside designation was used for this...
- This federal contract award, valued at $4,609.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, and is a firm fixed price delivery order. The contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $42,385.93 firm fixed price delivery order is for the supply of 4,564,054,872 units of Lidocaine 5% Patch 30s, a medical product, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp. is a delivery order worth $21,005.14 for the supply of 4558531687 - Lidocaine 5% Patch 30s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Lidocaine 5% Patches to support military treatment programs and facilities. The firm fixed price delivery order, valued at $8,056.91, has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,243.20 firm fixed price delivery order is for the supply of Lidocaine 5% Patch 30s, a prescription pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The firm-fixed-price contract has a ceiling value of $6,305.30 and a period of performance through January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4YPDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product, and has a ceiling value of $7,751.13. It is a firm fixed price delivery order contract with a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 3/27/24 |